Good afternoon, and welcome to the Marvell Technology Inc.'s Third Quarter of Fiscal Year 2026 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I will now ...
Zoetis Inc. ( ZTS) Discusses R&D Pipeline Progress and Strategic Vision in Animal Health Innovation December 2, 2025 8:30 AM EST Good morning, everyone. We will now move to the Q&A portion of our ...
Morning Overview on MSN
Old drug reverses Alzheimer’s signs in mice, researchers report
Researchers are reporting that an existing drug can roll back key signs of Alzheimer’s disease in mice, restoring memory ...
Second, for our mRNA cancer immunotherapies, we have recently provided 2 Phase II updates that support and inform our current ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback